Bone mineral density and adjuvant therapy in breast cancer survivors

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 257-261

  Crandall, C ^a,b   Petersen, L ^b   Ganz, P A ^b   Greendale, G A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Bone density; Breast cancer; Menopause; Osteoporosis

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANTINEOPLASTIC AGENTS; BONE DENSITY; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; SURVIVORS;

EID: 12344275501     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0804-3     Document Type: Article

References (37)

1. Breast Cancer Facts and Figures 2003-2004. American Cancer Society, Atlanta, Georgia, 2003
2. Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43, 1988
3. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR: Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276: 1404-1408, 1996
4. Nelson RL, Turyk M, Kim J, Persky V: Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2: 22, 2002
5. Nelson DA, Darga LL, Simon MS, Severson RK: Radial bone density and breast cancer risk in white and African-American women. Osteoporos Int, 2004
6. Zmuda JM, Cauley JA, Ljung BM, Bauer DC, Cummings SR, Kuller LH: Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Natl Cancer Inst 93: 930-936, 2001
7. Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, Schatzkin A, Levy D, Felson DT: Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 336: 611-617, 1997
8. Buist DS, LaCroix AZ, Barlow WE, White E, Cauley JA, Bauer DC, Weiss NS: Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States). Cancer Causes Control, 12: 213-222, 2001
9. van der Klift M, Laet CE, Coebergh JW, Hofman A, Pols HA: Bone mineral density and the risk of breast cancer: the Rotterdam Study. Bone, 32: 211-216, 2003
10. Nguyen TV, Center JR, Eisman JA: Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 36: 27-34, 2000
11. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP: Prevalence of low femoral bone density in older US adults from NHANES III. J Bone Miner Res 12: 1761-1768, 1997
12. Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA: Making effective use of tumor registries for cancer survivorship research. Cancer, 92: 1305-1314, 2001
13. Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE: Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21: 4184-4193, 2003
14. SAS Institute Inc. SAS/STAT Users Guide, Version 8.02. Cary, NC: SAS Institute Inc., 1989
15. Vehmanen L, Saarto T, Elomaa I, Makela P, Valimaki M, Blomqvist C: Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in pre-menopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 37: 2373-2378, 2001
16. Shapiro CL, Manola J, Leboff M: Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19: 3306-3311, 2001
17. Saarto T, Blomqvist C, Risteli J, Risteli L, Sarna S, Elomaa I: Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. Br J Cancer 78: 240-245, 1998
18. Headley JA, Theriault RL, LeBlanc AD, Vassilopoulou-Sellin R, Hortobagyi GN: Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. Cancer Invest 16: 6-11, 1998
19. Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I: Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15: 1341-1347, 1997
20. Bruning PF, Pit MJ, de Jong-Bakker M, van den Ende A, Hart A, van Enk A: Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br J Cancer 61: 308-310, 1990
21. Yoneda K, Tanji Y, Ikeda N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S: Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan. Cancer Lett 186: 223-230, 2002
22. Marttunen MB, Hietanen P, Titinen A, Roth HJ, Viinikka L, Ylikorkala O: Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer. Calcif Tissue Int 65: 365-368, 1999
23. Saarto T, Blomqvist C, Valimaki M, Makela P, Sarna S, Elomaa I: Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens. Br J Cancer 75: 602-605, 1997
24. Barni S, Lissoni P, Tancini G, Ardizzoia A, Cazzaniga M: Effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women. Tumori 82: 65-67, 1996
25. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S: Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14: 78-84, 1996
26. Love RR, Barden HS, Mazess RB, Epstein S, Chappell RJ: Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years. Arch Intern Med 154: 2585-2588, 1994
27. Kristensen B, Ejlertsen B, Dalgaard P, Larsen L, Holmegaard SN, Transbol I, Mouridsen HT: Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol 12: 992-997, 1994
28. Fornander T, Rutqvist LE, Sjoberg HE, Blomqvist L, Mattsson A, Glas U: Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncol 8: 1019-1024, 1990
29. Fornander T, Rutqvist LE, Wilking N, Carlstrom K, von Schoultz B: Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer. Eur J Cancer 29A: 497-500, 1993
30. Neal AJ, Evans K, Hoskin PJ: Does long-term administration of tamoxifen affect bone mineral density? Eur J Cancer 29A: 1971-1973, 1993
31. Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, Carbone PP, DeMets DL: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 326: 852-856, 1992
32. Fentiman IS, Saad Z, Caleffi M, Chaudary MA, Fogelman I: Tamoxifen protects against steroid-induced bone loss. Eur J Cancer 28: 684-685, 1992
33. Cuzick J, Allen D, Baum M, Barren J, Clark G, Kakkar V, Melissari E, Moniz C, Moore J, Parsons V, et al. Long term effects of tamoxifen. Biological effects of Tamoxifen Working Party. Eur J Cancer 29A: 15-21, 1992
34. Ryan WG, Wolter J, Bagdade JD: Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study. Osteoporos Int 2: 39-41, 1991
35. Kalef-Ezra JA, Pavlidis N, Klouvas G, Karantanas A, Hatzikonstantinou I, Glaros D: Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen. Breast Cancer Res Treat 37: 161-168, 1996
36. Greep NC, Giuliano AE, Hansen NM, Taketani T, Wang HJ, Singer FR: The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer. Am J Med 114: 653-659, 2003
37. Beckmann MW, Jap D, Djahansouzi S, Nestle-Kramling C, Kuschel B, Dall P, Brumm C, Bender HG: Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates. Oncology 60: 199-206, 2001